AmgenvsBristol-Myers Squibb

AMGN and BMY stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$443.89

Value $239B

-3.07%
AMGN's page

BMY

Bristol-Myers Squibb Company

$59.56

Value $121B

-2.92%
BMY's page

Amgen (AMGN) has a market value of $239B and Bristol-Myers Squibb (BMY) $121B. Over the last year, with dividends, AMGN moved +33.5% and BMY +32.9%. The P/E is 25.5 for AMGN and 13.1 for BMY. Dividend yield: AMGN 2.24%, BMY 4.23%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$239B

    BMY$121B

    AMGN is 2.0 times BMY

  • Revenue, 12 months

    AMGN$38.9B

    BMY$50.0B

    BMY is 1.3 times AMGN

  • Net income, 12 months

    AMGN$9.4B

    BMY$9.2B

    About the same

  • Operating margin

    AMGN32.4%

    BMY–

  • ROIC

    AMGN16.2%

    BMY14.1%

    2.1 points apart

  • P/E

    AMGN25.5

    BMY13.1

    AMGN is 1.9 times BMY

  • Dividend yield

    AMGN2.2%

    BMY4.2%

    2.0 points apart

  • 5-year return

    AMGN+149.9%

    BMY+23.2%

    126.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+149.9%

BMY+23.2%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsBMYWith dividends
1 year since November 17, 2025+33.5%Price +29.9%+32.9%Price +27.2%
3 years since November 17, 2023+81.6%+22.0% a yearPrice +67.3%+34.9%+10.5% a yearPrice +17.2%
5 years since November 17, 2021+149.9%+20.1% a yearPrice +115.7%+23.2%+4.3% a yearPrice +0.2%
10 years since November 18, 2016+308.8%+15.1% a yearPrice +205.6%+49.9%+4.1% a yearPrice +4.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenBMYBristol-Myers Squibb

Valuation

AMGNBMY
Valuation
Price$443.89$59.56
Market value$239B$121B
Enterprise value (EV)$280B$152B
P/E25.513.1
P/E, 5-year median23.017.8
P/B16.75.2
EV/EBIT22.213.4
Free cash flow yield4.0%7.7%

Results and growth

AMGNBMY
Results and growth
Revenue, 12 months$38.9B$50.0B
Net income, 12 months$9.4B$9.2B
Free cash flow, 12 months$9.6B$9.3B
Earnings per share, 12 months$17.25$4.51
Revenue growth, year on year10.0%-0.2%
Revenue growth a year, past+7.6%over 5 years+2.5%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNBMY
Margins and returns on capital
Gross margin70.9%69.2%
Operating margin32.4%–
Net margin24.1%18.5%
ROIC16.2%14.1%
ROE87.8%45.0%

Balance sheet

AMGNBMY
Balance sheet
Cash$13.2B$12.6B
Total debt$54.0B$44.8B
Net debt / EBITDA2.32.0
Interest cover4.8×6.9×

Dividends and buybacks

AMGNBMY
Dividends and buybacks
Dividend yield2.2%4.2%
Dividend per share, 12 months$9.94$2.52
Dividend growth a year, past+8.1%over 5 years+6.2%over 5 years
Buyback yield––
Shareholder yield2.2%4.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or BMY

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Bristol-Myers Squibb?

By market value, Amgen ($239B) is about 2.0 times Bristol-Myers Squibb ($121B), at today's prices.

How did AMGN and BMY stock do over the last 10 years?

Since November 18, 2016, AMGN's price moved +205.6% and BMY's +4.9%. With dividends: AMGN +308.8% (+15.1% a year), BMY +49.9% (+4.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or BMY?

The dividend yield at today's price is 2.24% for Amgen and 4.23% for Bristol-Myers Squibb. Over the last twelve months they paid $9.94 and $2.52 per share.

What is the P/E of AMGN and BMY?

At today's price, the P/E is 25.5 for AMGN and 13.1 for BMY. The median of the last five years was 23.0 and 17.8, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Bristol-Myers Squibb?

Over the last twelve months, the net margin was 24.1% for Amgen and 18.5% for Bristol-Myers Squibb, and the operating margin 32.4% and –. Revenue was $38.9B and $50.0B.

Which is the better investment, Amgen or Bristol-Myers Squibb?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.